Ellington Management Group’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-127
Closed -$142K 699
2017
Q2
$142K Buy
+127
New +$142K 0.02% 567